Business

Pyramidion Technology Group, Inc. (OTC: PYTG), Leafywell.com, Announces Medical Marijuana Advocate Dr. Canasi Advisory Board Appointee

Pyramidion Technology Group, Inc. (OTC: PYTG), Leafywell.com, Announces Medical Marijuana Advocate Dr. Canasi Advisory Board Appointee.

articleNxgen Brands Inc.November 8, 20184/company/pyramidion-technology-group-inc/news/pyramidion-technology-group-inc-otc-pytg-leafywellcom-announces-medical-marijuana-advocate-dr-canasi-advisory-board-appointee
Pyramidion Technology Group, Inc. (OTC: PYTG), Leafywell.com, Announces Medical Marijuana Advocate Dr. Canasi Advisory Board Appointee

About this update from Nxgen Brands Inc.

[{"type":"text","content":"\n\n\n\nPyramidion Technology Group, Inc. (OTC: PYTG), Leafywell.com, Announces Medical Marijuana Advocate Dr. Canasi Advisory Board Appointee\n\n\n\n\n\nPyramidion Technology Group, Inc. (OTC: PYTG), Leafywell.com, Announces Medical Marijuana Advocate Dr. Canasi Advisory Board Appointee\nPR Newswire\nWESTON, Florida, November 8, 2018\n\n\n\nWESTON, Florida, November 8, 2018 /PRNewswire/ --\n\nPyramidion Technology Group, Inc. (OTC: PYTG) today announces that Dr. Canasi, practicing internal medicine physician, advocate of medical marijuana, Cannabidiol (CBD), and other alternative medicines, is the latest addition to the specialist-comprised PYTG, Leafywell (Leafywell.com), Board of Advisors.\n\nLeafywell (Leafywell.com), a subsidiary of PYTG (OTC: \"PYTG\"), handles the production, manufacturing, and distribution of hemp-based Cannabidiol (CBD) products such as tinctures, creams, lotions, edible candies, at both the wholesale and retail level. In the retail market, products are found at Leafywell.com, and both select retail outlets and medical offices.\n\nThe current advisory board composition of PYTG consists of multiple currently-practicing medical professionals including board-certified cardiologist and board-certified internal medicine physician, Dr. Mark Sabbota, family medicine specialist, Dr. Michael McKenzie, MD, Dr. David M. Feldbaum MD, FACS, certified in vascular surgery by the American Board of Surgery, and board-certified Surgical Neurophysiologist, Antonio A. Sama, in addition to other industry-specific board members.\n\nThe latest board addition, Dr. Javier J. Canasi, is an internal medicine physician with an active patient-treating medical practice. Dr. Canasi is an advocate of alternative medicine including the both hemp-based CBD products, marijuana-based CBD, and medicinal marijuana, when appropriate for the particular medical condition.\n\nDr. Canasi, when asked, \"How do you view the role of CBD in medical treatment plans?\", Dr. Canasi responded candidly, \"I appreciate all types of medicine that help patients achieve their treatment goals and we are fortunate to live in a world in which we have options, healthy options. I am a strong advocate of incorporating CBD into a treatment, when appropriate, and in some cases, it is used as a stand-alone treatment and in others I suggest to my patients a mix of CBD...

More updates from Nxgen Brands Inc.